131 related articles for article (PubMed ID: 22630149)
1. Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.
Safari D; Marradi M; Chiodo F; Th Dekker HA; Shan Y; Adamo R; Oscarson S; Rijkers GT; Lahmann M; Kamerling JP; Penadés S; Snippe H
Nanomedicine (Lond); 2012 May; 7(5):651-62. PubMed ID: 22630149
[TBL] [Abstract][Full Text] [Related]
2. Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model.
Vetro M; Safari D; Fallarini S; Salsabila K; Lahmann M; Penadés S; Lay L; Marradi M; Compostella F
Nanomedicine (Lond); 2017 Jan; 12(1):13-23. PubMed ID: 27879152
[TBL] [Abstract][Full Text] [Related]
3. Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.
Safari D; Dekker HA; Joosten JA; Michalik D; de Souza AC; Adamo R; Lahmann M; Sundgren A; Oscarson S; Kamerling JP; Snippe H
Infect Immun; 2008 Oct; 76(10):4615-23. PubMed ID: 18678667
[TBL] [Abstract][Full Text] [Related]
4. Development of experimental carbohydrate-conjugate vaccines composed of Streptococcus pneumoniae capsular polysaccharides and the universal helper T-lymphocyte epitope (PADRE).
Alexander J; del Guercio MF; Frame B; Maewal A; Sette A; Nahm MH; Newman MJ
Vaccine; 2004 Jun; 22(19):2362-7. PubMed ID: 15193395
[TBL] [Abstract][Full Text] [Related]
5. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
Alonso de Velasco E; Verheul AF; van Steijn AM; Dekker HA; Feldman RG; Fernández IM; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H
Infect Immun; 1994 Mar; 62(3):799-808. PubMed ID: 7509318
[TBL] [Abstract][Full Text] [Related]
6. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF
Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969
[TBL] [Abstract][Full Text] [Related]
7. Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes.
Laferriere CA; Sood RK; de Muys JM; Michon F; Jennings HJ
Infect Immun; 1998 Jun; 66(6):2441-6. PubMed ID: 9596700
[TBL] [Abstract][Full Text] [Related]
8. Gold Nanoparticles as Carriers for Synthetic Glycoconjugate Vaccines.
Chiodo F; Marradi M
Methods Mol Biol; 2015; 1331():159-71. PubMed ID: 26169740
[TBL] [Abstract][Full Text] [Related]
9. [A new vaccine concept: polysaccharide conjugate vaccines].
Moreau M
Ann Pharm Fr; 1999 May; 57(3):223-31. PubMed ID: 10427857
[TBL] [Abstract][Full Text] [Related]
10. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Front Immunol; 2020; 11():578019. PubMed ID: 33343566
[TBL] [Abstract][Full Text] [Related]
11. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
12. Deciphering Antigenic Determinants of Streptococcus pneumoniae Serotype 4 Capsular Polysaccharide using Synthetic Oligosaccharides.
Geissner A; Pereira CL; Leddermann M; Anish C; Seeberger PH
ACS Chem Biol; 2016 Feb; 11(2):335-44. PubMed ID: 26674834
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197.
Mawas F; Niggemann J; Jones C; Corbel MJ; Kamerling JP; Vliegenthart JF
Infect Immun; 2002 Sep; 70(9):5107-14. PubMed ID: 12183560
[TBL] [Abstract][Full Text] [Related]
14. Synthetic carbohydrate-based vaccines: challenges and opportunities.
Mettu R; Chen CY; Wu CY
J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
[TBL] [Abstract][Full Text] [Related]
15. Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate.
Wang TT; Fellows PF; Leighton TJ; Lucas AH
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):231-7. PubMed ID: 15039099
[TBL] [Abstract][Full Text] [Related]
16. Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against
Seco BMS; Xu FF; Grafmüller A; Kottari N; Pereira CL; Seeberger PH
ACS Chem Biol; 2020 Sep; 15(9):2395-2405. PubMed ID: 32835479
[TBL] [Abstract][Full Text] [Related]
17. The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope.
Safari D; Dekker HA; Rijkers GT; van der Ende A; Kamerling JP; Snippe H
Glycoconj J; 2011 Dec; 28(8-9):557-62. PubMed ID: 21984010
[TBL] [Abstract][Full Text] [Related]
18. Electron beam fragmentation of bacterial polysaccharides as a method of producing oligosaccharides for the preparation of conjugate vaccines.
Pawlowski A; Svenson SB
FEMS Microbiol Lett; 1999 May; 174(2):255-63. PubMed ID: 10339817
[TBL] [Abstract][Full Text] [Related]
19. T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of
Middleton DR; Sun L; Paschall AV; Avci FY
J Immunol; 2017 Jul; 199(2):598-603. PubMed ID: 28566369
[TBL] [Abstract][Full Text] [Related]
20. High sensitive detection of carbohydrate binding proteins in an ELISA-solid phase assay based on multivalent glyconanoparticles.
Chiodo F; Marradi M; Tefsen B; Snippe H; van Die I; Penadés S
PLoS One; 2013; 8(8):e73027. PubMed ID: 24014084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
